Literature DB >> 6295958

Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

A Donohue-Rolfe, G T Keusch.   

Abstract

Treatment of Shigella dysenteriae 1 either with the antibiotic polymyxin B or by osmotic shock resulted in the release of 80 to 90% of the cytotoxin activity of the organism. Under the conditions employed, the release of toxin activity was accompanied by the appearance of a periplasmic enzyme, 5'-nucleotidase. There was no significant release of cytoplasmic contents, assessed by measurement of glucose-6-phosphate dehydrogenase activity. The release of cytotoxin and 5'-nucleotidase by polymyxin B were both dependent on the duration of incubation with, and the concentration of, the antibiotic. In terms of specific activity (cytotoxin activity per milligram of protein), the polymyxin B and osmotic shock extracts were 20- to 30-fold more active than crude toxin preparation derived from a whole-cell lysate. The data strongly support a periplasmic location for Shiga cytotoxin and the utility of the polymyxin B extraction to obtain starting material for toxin purification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295958      PMCID: PMC347936          DOI: 10.1128/iai.39.1.270-274.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Restriction in vivo. III. General effects of glucosylation and restriction on phage T4 gene expression and replication.

Authors:  K Dharmalingam; E B Goldberg
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

2.  Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis.

Authors:  P Gemski; A Takeuchi; O Washington; S B Formal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

3.  The 5'-nucleotidase of Escherichia coli. II. Surface localization and purification of the Escherichia coli 5'-nucleotidase inhibitor.

Authors:  H C Neu
Journal:  J Biol Chem       Date:  1967-09-10       Impact factor: 5.157

4.  Production and characterization of exotoxin(s) of Shigella dysenteriae type 1.

Authors:  J McIver; G F Grady; G T Keusch
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

Review 5.  Shigella toxin(s): description and role in diarrhea and dysentery.

Authors:  G T Keusch; A Donohue-Rolfe; M Jacewicz
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

6.  The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans.

Authors:  G T Keusch; M Jacewicz
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

7.  Lincomycin increases synthetic rate and periplasmic pool size for cholera toxin.

Authors:  M H Levner; C Urbano; B A Rubin
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

8.  The effect of toluene on the structure and permeability of the outer and cytoplasmic membranes of Escherichia coli.

Authors:  M J de Smet; J Kingma; B Witholt
Journal:  Biochim Biophys Acta       Date:  1978-01-04

9.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

10.  Release of surface enzymes in Enterobacteriaceae by osmotic shock.

Authors:  H C Neu; J Chou
Journal:  J Bacteriol       Date:  1967-12       Impact factor: 3.490

View more
  23 in total

1.  Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.

Authors:  M H Giaffer; C D Holdsworth; B I Duerden
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

2.  Cytotoxicity potential and genotypic characterization of Escherichia coli isolates from environmental and food sources.

Authors:  Yadilka Maldonado; Jennifer C Fiser; Cindy H Nakatsu; Arun K Bhunia
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

3.  Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.

Authors:  M L Suhan; C J Hovde
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

Review 5.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

6.  Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I.

Authors:  C J Hovde; S B Calderwood; J J Mekalanos; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Analysis of the roles of FlgP and FlgQ in flagellar motility of Campylobacter jejuni.

Authors:  Shawn M Sommerlad; David R Hendrixson
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

8.  Haemophilus influenzae pili are composite structures assembled via the HifB chaperone.

Authors:  J W St Geme; J S Pinkner; G P Krasan; J Heuser; E Bullitt; A L Smith; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 9.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

10.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.